These findings confirm previously published research (Castellano et al., 2017), expand on the potential mechanism for the beneficial effects of TIMP2, and provide important details for a therapeutic path forward for TIMP2 recombinant proteins in aging-related cognitive decline. This evidence concerns the gene TIMP2 and Mental deterioration.